期刊文献+

雷帕霉素对KKAy小鼠体重及胰岛素抵抗的影响 被引量:2

The effects of rapamycin on body weight and insulin resistance in KKAy mice
下载PDF
导出
摘要 目的探讨雷帕霉素对KKAy小鼠体重及胰岛素抵抗(IR)的影响。方法16周KKAy小鼠34只,随机分为对照组(NC组,12只)、雷帕霉素治疗组(R组,12只)、胰岛素治疗组(Ins组,10只),6只同龄C57BL与5只KKAy小鼠作为治疗前对照。结果治疗前KKAy小鼠体重、血糖、TG明显高于C57BL小鼠(体重:36.2±1.9gvs29.3±1.0g;血糖:13.4±1.7mmol/Lvs7.8±0.5mmol/L;TG:1.59±0.16mmol/Lvs0.75±0.09mmol/L;P均<0.01)。治疗4周后:R组体重(33.7±2.3g),低于NC组(38.2±1.5g)和Ins组(37.4±1.1g),差异有统计学意义(P均<0.05);R组血糖(17.2±7.3mmol/L),低于NC组(29.1±3.2mmol/L),差异有统计学意义(P<0.05);治疗8周后:R组体重(32.2±3.1g),低于NC组(39.3±2.8g),差异有统计学意义(P<0.05);血糖(18.2±3.7mmol/L),低于NC组(24.4±5.1mmol/L),差异无统计学意义(P=0.06)。胰岛素敏感试验表明:R组在注射胰岛素60min后,血糖降幅明显大于NC组(4.88±0.73mmol/Lvs2.65±2.12mmol/L,P<0.05)。结论雷帕霉素可减轻KKAy小鼠体重、改善IR、降低血糖。 Objective To investigate the effects of rapamycin on the body weight and insulin resistance in KKAy mice,a model of type 2 diabetes. Methods Five KKAy and six C57BL mice aged 16 weeks were randomly selected as pre-treatment control Others were randomized to receive physiological saline(group C, n=12), rapamycin(group R, n=12) and long-effective insulin(group I, n=10). The body weight and blood glucose level were evaluated at pre-treatment,4 and 8 weeks after the initiation of treatment, The insulin sensitivity test was conducted at 5^th week in group C and group R. Results The KKAy mice manifested obesity and higher levels of glucose and triglyceride as compared with C57BL mice. After 4 weeks of treatment, group R had a significantly lower levels of body weight (33.7±2.3 g vs 37.4± 1.1 g of group C, P〈0.05 vs 38.2±1.5 g of group I, P〈0.05) and of blood glucose ( 17.2± 7.3 mmol/L vs 29. 1 ±3.2 mmol/L of group C, P 〈0.05 ; vs 26.4 ± 4.3 mmol/L of group I, P〈0.09). At 8 week treatment, the body weight in group R was still lower than in group C(32.3±3.1 g vs 39.3±2.8 g,P〈0.05). The glucose level of group R was lower than that of group C (18.2±3.7 mmol/L vs 24.4±5.1 retool/L) but didn't get statistical difference (P〈0.06) The insulin sensitivity test revealed that the level of glucose decreased rapidly and was significantly lower in group R at 60 minutes after insulin injection as compared with group C(4.88〈0.73 mmol/L vs 2.65〈2.12 mmol/L,P〈0.05). Conclusions Rapamycin can decrease the body weight, blood glucose level, and can improve the insulin resistance in KKAy mice.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2007年第2期109-111,共3页 Chinese Journal of Diabetes
关键词 雷帕霉素 糖尿病 2型 体重 胰岛素抵抗 Rapamycin Diabetes mellitus, type 2 Body weight Insulin resistance
  • 相关文献

参考文献6

  • 1Khamzina L,Veilleux A,Bergeron S,et al.Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats:possible involvement in obesity-linked insulin resistance.Endocrinology,2005,146:1473-1481.
  • 2Ueno M,Carvalheira JB,Tambascia RC,et al.Regulation of insulin signaling by hyperinsulinaemia:role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway.Diabetologia,2005,48:506-518.
  • 3Briaud I,Dickson LM,Lingohr MK,et al.Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down regulates protein kinase B mediated signaling pathway in beta-cells.J Biol Chem,2005,280:2282-2293.
  • 4Picard F,et al.SRC 1 and TIF2 control energy balance between white and brown adipose tissues.Cell,2002,111:931-941.
  • 5Um SH,Frigerio.F,Watanabe.M,et al.Absence of S6K1 protects against age and diet-induced obesity while enhancing insulin sensitivity.Nature,2004,431:200-205.
  • 6Montagne J,Stewart M,Stocker H,et al.Drosophila S6 kinase:A regulator of cell size.Science,1999,285:2126-2129.

同被引文献20

  • 1Lamming DW, Ye L, Katajisto P, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity [ J ]. Science. 2012,335 (6076) : 1638 - 1643.
  • 2Hamada S, Hara K, Hamada T, et al. Upregulation of the mammalian target of rapamycin complex 1 pathway by ras homolog enriched in brain in pancreatic B-cells leads to increased B-cell mass and prevention of hyperglycemia [ J]. Diabetes. 2009, 58 : 1321 - 1332.
  • 3Zbang YY, Guo KY, Leblanc RE, et al. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms [ J]. Diabetes. 2007, 56 : 1647 - 1654.
  • 4She PX, Reid TM, Bronson SK, et al. Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle [ J ]. Cell Metabolism. 2007, 6:181 - 194.
  • 5Zhou YS(周迎生),Jetton TL, Goshorn S, et al. Transamination is required for α-ketoisoeaproate but not leucine to stimulate insulin secretion. JBC. 2010, 285(44) : 33718 -33726.
  • 6Marshall S. Role of insulin, adipocyte hormones, and nutrientsensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective of diabetes, obesity, and cancer [ J]. Science Signaling, 2006, 346 : 1 - 10.
  • 7Rachdi L, Balcazar N, Osorio-Duque F, et al. Disruption of Tsc2 in pancreatic cells induces cell mass expansion and improved glucose tolerance in a TORCl-dependent manner [ J]. PNAS. 2008, 105(27) : 9250 -9255.
  • 8Freudenberg A, Petzke KJ, Klaus S. Comparison of high-protein diets and leucine supplementation in the prevention of metabolic syndrome and related disorders in mice. J Nutr Biachem. 2012, Mar 7 [ Epub ahead of print].
  • 9何清华,周迎生,王征,王抒,牟忠卿,黎健,刘冬戈,迟家敏.2型糖尿病大鼠模型制备的影响因素及其特点[J].中国实验动物学报,2007,15(6):425-429. 被引量:38
  • 10Estacio R O, Schrier R W. Diabetic nephropathy : pathogenesis, di- agnosis,and prevention of progression [ J ]. Adv Intern Med, 2001, 46 : 359 - 408.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部